2007 annual financial data
Regeneron Pharmaceuticals 2007 Operating cash flow margin
Direct answer
Operating cash flow margin was 21.89%.
Operating income was -114,454,000 USD and net income was -105,600,000 USD.
Operating cash flow was 27,372,000 USD.
Get free Regeneron Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 125,024,000 USD
- Operating income
- -114,454,000 USD
- Net income
- -105,600,000 USD
- Operating cash flow
- 27,372,000 USD